Organization · Venture Capital
ShangBay Capital
ShangBay Capital is a venture capital firm based in Palo Alto, California, specializing in early-stage investments in medical devices, biotechnology, and healthcare technology. The firm focuses on addressing significant clinical needs through innovative solutions.
Overview
What ShangBay Capital does
What ShangBay Capital is
ShangBay Capital is a venture capital firm based in Palo Alto, California, specializing in early-stage investments in medical devices, biotechnology, and healthcare technology. The firm focuses on addressing significant clinical needs through innovative solutions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find ShangBay Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
ShangBay Capital as a funder
Investment thesis
ShangBay Capital focuses on addressing significant unmet clinical needs through innovative solutions in medical devices, biotechnology, and healthcare technology.
Focus narrative
ShangBay Capital invests in opportunities that demonstrate clinical benefits for unmet needs within medical devices, biopharma, and healthcare. The firm emphasizes a collaborative approach with entrepreneurs, aiming to facilitate the growth and success of startups through strategic partnerships and insights into market dynamics.
Value beyond capital
ShangBay Capital adds value to its portfolio companies through strategic partnerships, market insights, and a collaborative approach to commercialization. The firm actively engages with entrepreneurs to navigate the complexities of the healthcare market and leverage its extensive network for growth opportunities.
Focus and fit
- Stages
- Seed · Series A · Series B · Series C
- Sectors
- Biotech · Healthcare · Medical Devices
- Regions
- North AmericaAsia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 72
- Recorded notable exits
- Ceribell, Lucira Health, Arrinex, Apexigen, Berkeley Lights, and DeVoro Medical
Portfolio context
Notable portfolio companies include Ceribell, an AI-enabled EEG system; Avation Medical, which recently raised over $22M in a Series C; SetPoint Medical, focused on bioelectronic therapeutics; and Petal Surgical, which develops surgical devices. Other active investments include Modular Surgical, Refuge Biotech, and Huma.AI.
Common questions
What to know about ShangBay Capital
Upseed classifies ShangBay Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.